KYV-101 anti-CD19 CAR-T cell therapy: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

3

Conditions studied

1

US states with sites

1

Countries

Phase breakdown

Phase 1 1

Conditions being studied

Condition	Trials
Multiple Sclerosis	1
Multiple Sclerosis, Primary Progressive	1
Multiple Sclerosis, Secondary Progressive	1

Recruiting trials involving KYV-101 anti-CD19 CAR-T cell therapy

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
NCT06138132 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve KYV-101 anti-CD19 CAR-T cell therapy?

1 recruiting trial across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.